AngioChem

AngioChem

AngioChem

AngioChem develops new drugs that are capable of crossing the blood-brain barrier to treat brain diseases.
Founded
2003
Raised
$9.8M
Follow us
Alexa global traffic share
Latest funding Show all
$3,000,000
Venture capital - 2007
$6,000,000
Venture capital - 2005
Team Size
10+
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when AngioChem makes some noise.